---

Brought to you by RivalSense - an AI tool for monitoring any company.

RivalSense tracks the most important product launches, fundraising news, partnerships, hiring activities, pricing changes, tech news, vendors, corporate filings, media mentions, and other developments of companies you're following 💡

---

Bērnu klīniskā universitātes slimnīca

🌎 bkus.lv

Bērnu klīniskā universitātes slimnīca, also known as the Children's University Hospital of Latvia, is the largest specialized multidisciplinary children's medical treatment institution in Latvia. It provides state-paid medical services for children, including outpatient and inpatient care, and serves approximately 15,000 in-patient and over 300,000 outpatient appointments annually. The hospital aims to create a safe, high-quality, and child-friendly healthcare ecosystem, focusing on excellent treatment results and positive patient experiences.

---

Updates as of Sep 30, 2024

• On September 28, the State Police initiated a criminal case against Bērnu klīniskā universitātes slimnīca for alleged improper treatment.
• Bērnu klīniskā universitātes slimnīca successfully organized Pediatric Innovation Day 2024, bringing together key innovators and speakers.
• On September 27, Valdis Dombrovskis and Zane Petre visited Bērnu klīniskā universitātes slimnīca to review the use of EU Recovery Fund for the new 8000 m2 building housing the Ambulatory Health Center and Emergency Medical Center.
• Bērnu klīniskā universitātes slimnīca is the first institution to fully integrate the National Health Service's electronic cancer registry system.
• Bērnu klīniskā universitātes slimnīca is testing robotic colleagues as part of their ongoing innovation efforts.

• On September 24, Bērnu klīniskā universitātes slimnīca showcased its new building to Céline Gauer, head of the European Commission's Recovery and Resilience Task Force, highlighting the upcoming opening of the Ambulatory Health Center and Emergency Medical Center in early October.

---

Did you find it useful?

If you liked this report, consider following your own companies of interest. Receive weekly insights directly to your inbox using RivalSense.